Company / Interest Expense
MARAVAI LIFESCIENCES HOLDINGS, INC. Interest Expense History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$45.9M
FY2023
5-year range
$20.4M / $45.9M
FY2019-FY2023
Trend
+124.8%
vs FY2022
Sector context
#14 of 44
Health Care
What the data says
At $46M, MARAVAI LIFESCIENCES HOLDINGS, INC.'s interest expense ranks #31 of 44 in the Health Care sector. Interest Expense returned to growth in FY2023 after 2 years of decline, reaching $46M.
Based on SEC 10-K filings.
$46M in FY2023 with a 3-year CAGR of +14.3%.
Increased from $30M to $46M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#31 of 44 in Health CareTop 68% of 44This company $45.9M Sector average $291.0M
▼
-84.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +14.3%, indicating consistent growth.
- In FY2023, interest expense increased 124.8% year-over-year.
- Ranks #14 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $45.9M | +124.8% |
| FY2022 | $20.4M | -32.5% |
| FY2021 | $30.3M | -1.6% |
| FY2020 | $30.7M | +2.6% |
| FY2019 | $30.0M | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026